Deerfield Management Discloses Stake In Post-IPO Audentes Therapeutics (BOLD)
James E. Flynn and his fund, Deerfield Management, have disclosed a stake in Audentes Therapeutics Inc (NASDAQ:BOLD), a company that has recently closed its initial public offering.
